Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Apr 05, 2019 4:01pm
184 Views
Post# 29589783

RE:New Equity could be Pref or diffrent share class -not common

RE:New Equity could be Pref or diffrent share class -not commonProbably not a good way to go for curent shareholders since the new class of shares, often called preferred, usually has a conversion option to common that would heavily dilute the common when eventually exercised - it is a ticking time bomb.

The only solution for the current shareholders, and breach of fiduciary duty by management if not fully looked into, is to consider and reach the value in the assets that we all know is high even if not liquid at the moment. If the only wqy to reach this asset value is to put the co on the block - then so be it. This threat is the only thing that may prevent TVto insist on clearing their loan for new equity at current super low prices if they feqar losing the PLI assets to some other major biopharma willing to pony up for full control of the assets PLI owns. ($70 MIL IS CHUMP CHANGE TO THESE ENTITIES (INCLUDING TV). Hopefully TV will play fair and not attempt to force the total dilution of shareholders in TV's favor and settle for something in between so all can live and fight another day.
Bullboard Posts